Fatty acids and signalling in endothelial cells

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 82, Issue 4-6, 2010, Pages 189-198

  Ringseis, Robert ^a   Eder, Klaus ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CELL ADHESION MOLECULE; CONJUGATED LINOLEIC ACID; DOCOSAHEXAENOIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; FATTY ACID; ICOSANOID; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LINOLEIC ACID; MONOUNSATURATED FATTY ACID; NITRIC OXIDE; OLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RETINOID X RECEPTOR; SATURATED FATTY ACID; TRANS FATTY ACID;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL FUNCTION; DIETARY INTAKE; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HUMAN; IN VITRO STUDY; MEDIATOR RELEASE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; CARDIOVASCULAR DISEASES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FATTY ACIDS; HUMANS; MODELS, BIOLOGICAL; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; RETINOID X RECEPTORS; SIGNAL TRANSDUCTION;

EID: 77951978107     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2010.02.022     Document Type: Article

References (134)

1. Schwartz S.M. Role of endothelial integrity in atherosclerosis. Artery 1980, 8:305-314.
2. Lloyd-Jones D., Adams R., Carnethon M., et al. Heart disease and stroke statistics-2009 update: a report from the American Heart association statistics committee and stroke statistics subcommittee. Circulation 2009, 119:e21-e181.
3. Psota T.L., Gebauer S.K., Kris-Etherton P. Dietary omega-3 fatty acid intake and cardiovascular risk. Am. J. Cardiol. 2006, 98:3i-18i.
4. Willett W.C., Stampfer M.J., Manson J.E., et al. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 1993, 341:581-585.
5. Pietinen P., Ascherio A., Korhonen P., et al. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am. J. Epidemiol. 1997, 145:876-887.
6. Oomen C.M., Ocke M.C., Feskens E.J., van Erp-Barrt M.J., Kok F.J., Kromhout D. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet 2001, 357:746-751.
7. Doran A.C., Meller N., McNamara C.A. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arteriosclerosis Thromb. Vasc. Biol. 2008, 28:812-819.
8. Cines D.B., Pollak E.S., Buck C.A., et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998, 91:3527-3561.
9. Giannotti G., Landmesser U. Endothelial dysfunction as an early sign of atherosclerosis. Herz 2007, 32:568-572.
10. Pearson J.D. Normal endothelial cell function. Lupus 2000, 9:183-188.
11. Förstermann U., Mügge A., Bode S.M., Frölich J.C. Response of human coronary arteries to aggregating platelets: importance of endothelium-derived relaxing factor and prostanoids. Circ. Res. 1988, 63:306-312.
12. Otsuji S., Nakajima O., Waku S., et al. Attenuation of acetylcholine-induced vasoconstriction by l-arginine is related to the progression of atherosclerosis. Am. Heart J. 1995, 129:1094-1100.
13. Rao R.M., Yang L., Garcia-Cardena G., Luscinskas F.W. Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circ. Res. 2007, 101:234-247.
14. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
15. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 2005, 352:1685-1695.
16. Chinetti G., Fruchart J.C., Staels B. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflammation Res. 2000, 49:497-505.
17. Duval C., Chinetti G., Trottein F., Fruchart J.C., Staels B. The role of PPARs in atherosclerosis. Trends Mol. Med. 2002, 8:422-430.
18. Marx N., Duez H., Fruchart J.C., Staels B. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. Circ. Res. 2004, 94:1168-1178.
19. Wang P., Anderson P.O., Chen S., Paulsson K.M., Sjögren H.O., Li S. Inhibition of the transcription factors AP-1 and NF-κB in CD4 T cells by peroxisome proliferator-activated receptor γ ligands. Int. Immunopharmacol. 2001, 1:803-812.
20. Göttlicher M., Widmark E., Li Q., Gustafsson J.A. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA 1992, 89:4653-4657.
21. Forman B.M., Chen J., Evans R.M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and γ. Proc. Natl. Acad. Sci. USA 1997, 94:4312-4317.
22. 2 metabolite binds peroxisome proliferator-activated receptor and promotes adipocyte differentiation. Cell 1995, 83:803-812.
23. Krey G., Braissant O., L'Horset F., et al. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 1997, 11:779-791.
24. Ringseis R., Eder K. Influence of conjugated linoleic acids on functional properties of vascular cells. Br. J. Nutr. 2009, 22:1-18.
25. Wan Y.J., An D., Cai Y., et al. Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver. Mol. Cell. Biol. 2000, 20:4436-4444.
26. Germain P., Chambon P., Eichele G., et al. International Union of Pharmacology. LXIII. Retinoid X receptors. Pharmacol. Rev. 2006, 58:760-772.
27. Heyman R.A., Mangelsdorf D.J., Dyck J.A., et al. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 1992, 68:397-406.
28. De Urquiza A.M., Liu S., Sjoberg M., et al. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 2000, 290:2140-2144.
29. Lengqvist J., Mata De Urquiza A., Bergman A.C., et al. Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor α ligand-binding domain. Mol. Cell. Proteomics 2004, 3:692-703.
30. Fan Y.Y., Spencer T.E., Wang N., Moyer M.P., Chapkin R.S. Chemopreventive n-3 fatty acids activate RXRα in colonocytes. Carcinogenesis 2003, 24:1541-1548.
31. Lampen A., Meyer S., Nau H. Phytanic acid and docosahexaenoic acid increase the metabolism of all-trans-retinoic acid and CYP26 gene expression in intestinal cells. Biochim. Biophys. Acta 2001, 1521:97-106.
32. Lemotte P.K., Keidel S., Apfel C.M. Phytanic acid is a retinoid X receptor ligand. Eur. J. Biochem. 1996, 236:328-333.
33. Claudel T., Leibowitz M.D., Fievet C., et al. Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor. Proc. Natl. Acad. Sci. USA 2001, 98:2610-2615.
34. Lalloyer F., Fiévet C., Lestavel S., et al. The RXR agonist bexarotene improves cholesterol homeostasis and inhibits atherosclerosis progression in a mouse model of mixed dyslipidemia. Arteriosclerosis Thromb. Vasc. Biol. 2006, 26:2731-2737.
35. Chai D., Wang B., Shen L., Pu J., Zhang X.K., He B. RXR agonists inhibit high-glucose-induced oxidative stress by repressing PKC activity in human endothelial cells. Free Radical Biol. Med. 2008, 44:1334-1347.
36. De Martin R., Hoeth M., Hofer-Warbinek R., Schmid J.A. The transcription factor NF-κB and the regulation of vascular cell function. Arteriosclerosis Thromb. Vasc. Biol. 2000, 20:E83-E88.
37. Jones W.K., Brown M., Wilhide M., He S., Ren X. NF-κB in cardiovascular disease: diverse and specific effects of a "general" transcription factor?. Cardiovasc. Toxicol. 2005, 5:183-202.
38. Hennig B., Toborek M., Joshi-Barve S., et al. Linoleic acid activates nuclear transcription factor-kappa B (NF-κB) and induces NF-κB-dependent transcription in cultured endothelial cells. Am. J. Clin. Nutr. 1996, 63:322-328.
39. Toborek M., Barger S.W., Mattson M.P., Barve S., McClain C.J., Hennig B. Linoleic acid and TNF-α cross-amplify oxidative injury and dysfunction of endothelial cells. J. Lipid Res. 1996, 37:123-135.
40. Hennig B., Meerarani P., Ramadass P., Watkins B.A., Toborek M. Fatty acid-mediated activation of vascular endothelial cells. Metabolism 2000, 49:1006-1013.
41. Park H.J., Lee Y.W., Hennig B., Toborek M. Linoleic acid-induced VCAM-1 expression in human microvascular endothelial cells is mediated by the NF-kappa B-dependent pathway. Nutr. Cancer 2001, 41:126-134.
42. Dichtl W., Ares M.P., Jönson A.N., et al. Linoleic acid-stimulated vascular adhesion molecule-1 expression in endothelial cells depends on nuclear factor-κB activation. Metabolism 2002, 51:327-333.
43. Toborek M., Lee Y.W., Garrido R., Kaiser S., Hennig B. Unsaturated fatty acids selectively induce an inflammatory environment in human endothelial cells. Am. J. Clin. Nutr. 2002, 75:119-125.
44. Reiterer G., Toborek M., Hennig B. Quercetin protects against linoleic acid-induced porcine endothelial cell dysfunction. J. Nutr. 2004, 134:771-775.
45. Saraswathi V., Wu G., Toborek M., Hennig B. Linoleic acid-induced endothelial activation: role of calcium and peroxynitrite signaling. J. Lipid Res. 2004, 45:794-804.
46. Hennig B., Lei W., Arzuaga X., Ghosh D.D., Saraswathi V., Toborek M. Linoleic acid induces proinflammatory events in vascular endothelial cells via activation of PI3K/Akt and ERK1/2 signaling. J. Nutr. Biochem. 2006, 17:766-772.
47. Wang L., Lim E.J., Toborek M., Hennig B. The role of fatty acids and caveolin-1 in tumor necrosis factor alpha-induced endothelial cell activation. Metabolism 2008, 57:1328-1339.
48. Zheng Y., Lim E.J., Wang L., Smart E.J., Toborek M., Hennig B. Role of caveolin-1 in EGCG-mediated protection against linoleic-acid-induced endothelial cell activation. J. Nutr. Biochem. 2009, 20:202-209.
49. Sizemore N., Leung S., Stark G.R. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Mol. Cell. Biol. 1999, 19:4798-4805.
50. Madrid L.V., Mayo M.W., Reuther J.Y., Baldwin A.S. Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem. 2001, 276:18934-18940.
51. Huang Z.H., Bates E.J., Ferrante J.V., et al. Inhibition of stimulus-induced endothelial cell intercellular adhesion molecule-1, E-selectin, and vascular cellular adhesion molecule-1 expression by arachidonic acid and its hydroxy and hydroperoxy derivatives. Circ. Res. 1997, 80:149-158.
52. Stuhlmeier K.M., Kao J.J., Bach F.H. Arachidonic acid influences proinflammatory gene induction by stabilizing the inhibitor-kappaBalpha/nuclear factor-kappaB (NF-kappaB) complex, thus suppressing the nuclear translocation of NF-kappaB. J. Biol. Chem. 1997, 272:24679-24683.
53. Ciapaite J., van Bezu J., van Eikenhorst G., et al. Palmitate and oleate have distinct effects on the inflammatory phenotype of human endothelial cells. Biochim. Biophys. Acta 2007, 1771:147-154.
54. Weber C., Erl W., Pietsch A., Danesch U., Weber P.C. Docosahexaenoic acid selectively attenuates induction of vascular cell adhesion molecule-1 and subsequent monocytic cell adhesion to human endothelial cells stimulated by tumor necrosis factor-α. Arteriosclerosis Thromb. Vasc. Biol. 1995, 15:622-628.
55. Chen W., Esselman W.J., Jump D.B., Busik J.V. Anti-inflammatory effect of docosahexaenoic acid on cytokine-induced adhesion molecule expression in human retinal vascular endothelial cells. Invest. Ophthalmol. Visual Sci. 2005, 46:4342-4347.
56. Goua M., Mulgrew S., Frank J., Rees D., Sneddon A.A., Wahle K.W. Regulation of adhesion molecule expression in human endothelial and smooth muscle cells by omega-3 fatty acids and conjugated linoleic acids: involvement of the transcription factor NF-κB?. Prostaglandins Leukotrienes Essent. Fatty Acids 2008, 78:33-43.
57. Xue H., Wan M., Song D., Li Y., Li J. Eicosapentaenoic acid and docosahexaenoic acid modulate mitogen-activated protein kinase activity in endothelium. Vasc. Pharmacol. 2006, 44:434-439.
58. Carluccio M.A., Massaro M., Bonfrate C., et al. Oleic acid inhibits endothelial activation: a direct vascular antiatherogenic mechanism of a nutritional component in the mediterranean diet. Arteriosclerosis Thromb. Vasc. Biol. 1999, 19:220-228.
59. Schleser S., Ringseis R., Eder K. Conjugated linoleic acids have no effect on TNFα-induced adhesion molecule expression, U937 monocyte adhesion, and chemokine release in human aortic endothelial cells. Atherosclerosis 2006, 186:337-344.
60. Sneddon A.A., McLeod E., Wahle K.W., Arthur J.R. Cytokine-induced monocyte adhesion to endothelial cells involves platelet-activating factor: suppression by conjugated linoleic acid. Biochim. Biophys. Acta 2006, 1761:793-801.
61. Spector A.A., Hoak J.C., Fry G.L., Denning G.M., Stoll L.L., Smith J.B. Effect of fatty acid modification on prostacyclin production by cultured human endothelial cells. J. Clin. Invest. 1980, 65:1003-1012.
62. Endresen M.J., Tøsti E., Heimli H., Lorentzen B., Henriksen T. Effects of free fatty acids found increased in women who develop pre-eclampsia on the ability of endothelial cells to produce prostacyclin, cGMP and inhibit platelet aggregation. Scand. J. Clin. Lab. Invest. 1994, 54:549-557.
63. Spector A.A., Yorek M.A. Membrane lipid composition and cellular function. J. Lipid Res. 1985, 26:1015-1035.
64. Vossen R.C., van Dam-Mieras M.C., Lemmens P.J., Hornstra G., Zwaal R.F. Membrane fatty acid composition and endothelial cell functional properties. Biochim. Biophys. Acta 1991, 1083:243-251.
65. Couloubaly S., Deloménie C., Rousseau D., Paul J.L., Grynberg A., Pourci M.L. Fatty acid incorporation in endothelial cells and effects on endothelial nitric oxide synthase. Eur. J. Clin. Invest. 2007, 37:692-699.
66. Davda R.K., Stepniakowski K.T., Lu G., Ullian M.E., Goodfriend T.L., Egan B.M. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension 1995, 26:764-770.
67. Moers A., Schrezenmeir J. Palmitic acid but not stearic acid inhibits NO-production in endothelial cells. Exp. Clin. Endocrinol. Diabetes 1997, 105S:78-80.
68. Zhu W., Smart E.J. Myristic acid stimulates endothelial nitric-oxide synthase in a CD36- and an AMP kinase-dependent manner. J. Biol. Chem. 2005, 280:29543-29550.
69. Kuroda R., Hirata K., Kawashima S., Yokoyama M. Unsaturated free fatty acids inhibit Ca2+ mobilization and NO release in endothelial cells. Kobe J. Med. Sci. 2001, 47:211-219.
70. Artwohl M., Roden M., Waldhäusl W., Freudenthaler A., Baumgartner-Parzer S.M. Free fatty acids trigger apoptosis and inhibit cell cycle progression in human vascular endothelial cells. FASEB J. 2004, 18:146-158.
71. Achard F., Gilbert M., Bénistant C., et al. Eicosapentaenoic and docosahexaenoic acids reduce PGH synthase 1 expression in bovine aortic endothelial cells. Biochem. Biophys. Res. Commun. 1997, 241:513-518.
72. 2+ and phospholipids. J. Biol. Chem. 1986, 261:15424-15429.
73. Lu G., Morinelli T.A., Meier K.E., Rosenzweig S.A., Egan B.M. Oleic acid induced mitogenic signalling in human aortic smooth muscle cells: a role for protein kinase C. J. Invest. Med. 1995, 43:375.
74. Herrera M.D., Pérez-Guerrero C., Marhuenda E., Ruiz-Gutiérrez V. Effects of dietary oleic-rich oils (virgin olive and high-oleic-acid sunflower) on vascular reactivity in Wistar-Kyoto and spontaneously hypertensive rats. Br. J. Nutr. 2001, 86:349-357.
75. Chisaki K., Okuda Y., Suzuki S., et al. Eicosapentaenoic acid suppresses basal and insulin-stimulated endothelin-1 production in human endothelial cells. Hypertension Res. 2003, 26:655-661.
76. Park J.Y., Kim Y.M., Song H.S., et al. Oleic acid induces endothelin-1 expression through activation of protein kinase C and NF-κB. Biochem. Biophys. Res. Commun. 2003, 303:891-895.
77. Spector A.A., Kaduce T.L., Hoak J.C., Fry G.L. Utilization of arachidonic and linoleic acids by cultured human endothelial cells. J. Clin. Invest. 1981, 68:1003-1011.
78. Garcia M.C., Sprecher H., Rosenthal M.D. Chain elongation of polyunsaturated fatty acids by vascular endothelial cells: studies with arachidonate analogues. Lipids 1990, 25:211-215.
79. 2 and arachidonic acid to prostacyclin by cultured human endothelial cells. J. Biol. Chem. 1978, 253:7138-7141.
80. Nordøy A., Svensson B., Hoak J.C. The effects of albumin bound fatty acids on the platelet inhibitory function of human endothelial cells. Eur. J. Clin. Invest. 1979, 9:5-10.
81. Cosentino F., Lüscher T.F. Tetrahydrobiopterin and endothelial nitric oxide synthase activity. Cardiovasc. Res. 1999, 43:274-278.
82. Tardivel S., Gousset-Dupont A., Robert V., Pourci M.L., Grynberg A., Lacour B. Protective effects of EPA and deleterious effects of DHA on eNOS activity in Ea hy 926 cultured with lysophosphatidylcholine. Lipids 2009, 44:225-235.
83. Jamin S.P., Crabos M., Catheline M., Martin-Chouly C., Legrand A.B., Saïag B. Eicosapentaenoic acid reduces thrombin-evoked release of endothelin-1 in cultured bovine endothelial cells. Res. Commun. Mol. Pathol. Pharmacol. 1999, 105:271-281.
84. Hadjiagapiou C., Kaduce T.L., Spector A.A. Eicosapentaenoic acid utilization by bovine aortic endothelial cells: effects on prostacyclin production. Biochim. Biophys. Acta 1986, 875:369-381.
85. Lands W.E., Byrnes M.J. The influence of ambient peroxides on the conversion of 5,8,11,14,17-eicosapentaenoic acid to prostaglandins. Prog. Lipid Res. 1981, 20:287-290.
86. Spector A.A., Kaduce T.L., Figard P.H., Norton K.C., Hoak J.C., Czervionke R.L. Eicosapentaenoic acid and prostacyclin production by cultured human endothelial cells. J. Lipid Res. 1983, 24:1595-1604.
87. Serhan C.N., Hong S., Gronert K., et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 2002, 196:1025-1037.
88. Schwab J.M., Chiang N., Arita M., Serhan C.N. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 2007, 447:869-874.
89. Okuda Y., Kawashima K., Sawada T., et al. Eicosapentaenoic acid enhances nitric oxide production by cultured human endothelial cells. Biochem. Biophys. Res. Commun. 1997, 232:487-491.
90. 2+)-independent activation and translocation of endothelial nitric oxide synthase and endothelium-dependent vasorelaxation. FEBS Lett. 2001, 487. pp. 361-366.
91. Li Q., Zhang Q., Wang M., et al. Docosahexaenoic acid affects endothelial nitric oxide synthase in caveolae. Arch. Biochem. Biophys. 2007, 466:250-259.
92. Moncada S., Higgs E.A. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur. J. Clin. Invest. 1991, 21:361-374.
93. Shimokawa H., Aarhus L.L., Vanhoutte P.M. Dietary omega 3 polyunsaturated fatty acids augment endothelium-dependent relaxation to bradykinin in coronary microvessels of the pig. Br. J. Pharmacol. 1988, 95:1191-1196.
94. Lockette W.E., Webb R.C., Culp B.R., Pitt B. Vascular reactivity and high dietary eicosapentaenoic acid. Prostaglandins 1982, 24:631-639.
95. Minshall R.D., Sessa W.C., Stan R.V., Anderson R.G., Malik A.B. Caveolin regulation of endothelial function. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 285:L1179-L1183.
96. 2+ entry. J. Biol. Chem. 2000, 275:17979-17985.
97. Shaul P.W., Smart E.J., Robinson L.J., et al. Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae. J. Biol. Chem. 1996, 271:6518-6522.
98. Li Q., Zhang Q., Wang M., et al. Eicosapentaenoic acid modifies lipid composition in caveolae and induces translocation of endothelial nitric oxide synthase. Biochimie 2007, 89:169-177.
99. Lee T.H., Hoover R.L., Williams J.D., et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N. Engl. J. Med. 1985, 312:1217-1224.
100. Stebbins C.L., Stice J.P., Hart C.M., Mbai F.N., Knowlton A.A. Effects of dietary decosahexaenoic acid (DHA) on eNOS in human coronary artery endothelial cells. J. Cardiovasc. Pharmacol. Ther. 2008, 13:261-268.
101. Coen P., Cummins P., Birney Y., Devery R., Cahill P. Modulation of nitric oxide and 6-keto-prostaglandin F(1α) production in bovine aortic endothelial cells by conjugated linoleic acid. Endothelium 2004, 11:211-220.
102. Eder K., Schleser S., Becker K., Körting R. Conjugated linoleic acids lower the release of eicosanoids and nitric oxide from human aortic endothelial cells. J. Nutr. 2003, 133:4083-4089.
103. Torres-Duarte A.P., Vanderhoek J.Y. Conjugated linoleic acid exhibits stimulatory and inhibitory effects on prostanoid production in human endothelial cells and platelets. Biochim. Biophys. Acta 2003, 1640:69-76.
104. Urquhart P., Parkin S.M., Rogers J.S., Bosley J.A., Nicolaou A. The effect of conjugated linoleic acid on arachidonic acid metabolism and eicosanoid production in human saphenous vein endothelial cells. Biochim. Biophys. Acta 2002, 1580:150-160.
105. Eder K., Slomma N., Becker K. Trans-10,cis-12 conjugated linoleic acid suppresses the desaturation of linoleic and α-linolenic acids in HepG2 cells. J. Nutr. 2002, 132:1115-1121.
106. 2 activity by conjugated linoleic acids in human macrophages. Eur. J. Nutr. 2007, 46:28-33.
107. Nugteren D.H., Christ-Hazelhof E. Naturally occurring conjugated octadecatrienoic acids are strong inhibitors of prostaglandin biosynthesis. Prostaglandins 1987, 33:403-417.
108. Bulgarella J.A., Patton D., Bull A.W. Modulation of prostaglandin H synthase activity by conjugated linoleic acid (CLA) and specific CLA isomers. Lipids 2001, 36:407-412.
109. Ringseis R., Müller A., Herter C., Gahler S., Steinhart H., Eder K. CLA isomers inhibit TNFα-induced eicosanoid release from human vascular smooth muscle cells a PPARγ ligand-like action. Biochim. Biophys. Acta 2006, 1760:290-300.
110. Jenko K.J., Vanderhoek J.Y. Conjugated linoleic acids and CLA-containing phospholipids inhibit NO formation in aortic endothelial cells. Lipids 2008, 43:335-342.
111. Dancu M.B., Berardi D.E., Vanden Heuvel J.P., Tarbell J.M. Atherogenic endothelial cell eNOS and ET-1 Responses to asynchronous hemodynamics are mitigated by conjugated linoleic acid. Ann. Biomed. Eng. 2007, 35:1111-1119.
112. Satoh H., Tsukamoto K., Hashimoto Y., et al. Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARγ on vascular endothelial function. Biochem. Biophys. Res. Commun. 1999, 254:757-763.
113. Degner S.C., Kemp M.Q., Bowden G.T., Romagnolo D.F. Conjugated linoleic acid attenuates cyclooxygenase-2 transcriptional activity via an anti-AP-1 mechanism in MCF-7 breast cancer cells. J. Nutr. 2006, 136:421-427.
114. Lopez-Garcia E., Schulze M.B., Meigs J.B. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J. Nutr. 2005, 135:562-566.
115. Baer D.J., Judd J.T., Clevidence B.A., Tracy R.P. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am. J. Clin. Nutr. 2004, 79:969-973.
116. De Roos N.M., Bots M.L., Katan M.B. Replacement of dietary saturated fatty acids by trans fatty acids lowers serum HDL cholesterol and impairs endothelial function in healthy men and women. Arteriosclerosis Thromb. Vasc. Biol. 2001, 21:1233-1237.
117. De Roos N.M., Siebelink E., Bots M.L., van Tol A., Schouten E.G., Katan M.B. Trans monounsaturated fatty acids and saturated fatty acids have similar effects on postprandial flow-mediated vasodilation. Eur. J. Clin. Nutr. 2002, 56:674-679.
118. Kummerow F.A., Mahfouz M.M., Zhou Q. Trans fatty acids in partially hydrogenated soybean oil inhibit prostacyclin release by endothelial cells in presence of high level of linoleic acid. Prostaglandins Other Lipid Mediators 2007, 84:138-153.
119. Loï C., Chardigny J.M., Cordelet C., et al. Incorporation and metabolism of trans 20:5 in endothelial cells. Effect on prostacyclin synthesis. Lipids 2000, 35:911-918.
120. Shaw D.I., Hall W.L., Jeffs N.R., Williams C.M. Comparative effects of fatty acids on endothelial inflammatory gene expression. Eur. J. Nutr. 2007, 46:321-328.
121. Holthe M.R., Andersson Y., Lyberg T. Lack of proinflammatory effects of free fatty acids on human umbilical cord vein endothelial cells and leukocytes. Acta Obstet. Gynecol. Scand. 2005, 84:672-678.
122. De Caterina R., Bernini W., Carluccio M.A., Liao J.K., Libby P. Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids. J. Lipid Res. 1998, 39:1062-1070.
123. Reissig D., Rassoul F., Salvetter J., Wagner O., Richter V. Effect of fatty acids on expression of endothelial leukocyte adhesion molecules. Eur. J. Nutr. 2003, 42:224-227.
124. Massaro M., Carluccio M.A., Paolicchi A., Bosetti F., Solaini G., De Caterina R. Mechanisms for reduction of endothelial activation by oleate: inhibition of nuclear factor-kappaB through antioxidant effects. Prostaglandins Leukotrienes Essent. Fatty Acids 2002, 67:175-181.
125. De Caterina R., Libby P. Control of endothelial leukocyte adhesion molecules by fatty acids. Lipids 1996, 31S:S57-S63.
126. Collie-Duguid E.S., Wahle K.W. Inhibitory effect of fish oil n-3 polyunsaturated fatty acids on the expression of endothelial cell adhesion molecules. Biochem. Biophys. Res. Commun. 1996, 220:969-974.
127. De Caterina R., Cybulsky M.I., Clinton S.K., Gimbrone M.A., Libby P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arteriosclerosis Thromb. 1994, 14:1829-1836.
128. De Caterina R., Massaro M. Omega-3 fatty acids and the regulation of expression of endothelial pro-atherogenic and pro-inflammatory genes. J. Membr. Biol. 2005, 206:103-116.
129. Yamada H., Yoshida M., Nakano Y., et al. In vivo and in vitro inhibition of monocyte adhesion to endothelial cells and endothelial adhesion molecules by eicosapentaenoic acid. Arteriosclerosis Thromb. Vasc. Biol. 2008, 28:2173-2179.
130. Sanderson P., Calder P.C. Dietary fish oil diminishes lymphocyte adhesion to macrophage and endothelial cell monolayers. Immunology 1998, 94:79-87.
131. Collins T., Read M.A., Neish A.S., Whitley M.Z., Thanos D., Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J. 1995, 9:899-909.
132. Calder P.C. Polyunsaturated fatty acids and inflammation. Prostaglandins Leukotrienes Essent. Fatty Acids 2006, 75:197-202.
133. Miles E.A., Thies F., Wallace F.A., et al. Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations. Clin. Sci. (London) 2001, 100:91-100.
134. Kalogeropoulou K., Mortzos G., Migdalis I., et al. Carotid atherosclerosis in type 2 diabetes mellitus: potential role of endothelin-1, lipoperoxides, and prostacyclin. Angiology 2002, 53:279-285.